Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$23.04M+3.2%$22.34M+2.7%$21.75M+4.0%$20.9M+3.0%$20.29M+2.6%
$11.74M-15.2%$13.85M-14.7%$16.23M-87.9%$134.23M+3.4%$129.79M-1.5%
$4.75M+3.6%$4.58M-12.6%$5.24M+1.9%$5.14M-12.4%$5.87M-7.8%
$19.79M+126%$8.75M-48.4%$16.95M-33.5%
$21.15M+222%$6.57M-25.7%$8.85M-37.5%
$5.51M+331%$1.28M
-$1.14M-5.8%-$1.08M+22.3%-$1.38M-22.0%-$1.13M-73.9%-$652K+15.0%
$2.29M-7.8%$2.48M+31.4%$1.89M-57.3%$4.43M
$88.77M-11.5%$100.26M+13.9%$87.99M+47.1%$59.82M-13.3%$69.02M+14.8%
$476K-35.3%$736K-13.5%$851K-2.4%$872K+4.2%$837K+24.7%
-$31.43M+2.5%-$32.23M+5.6%-$34.14M-5.8%-$32.25M+0.3%-$32.35M-6.4%
$88.93M-1.0%$89.84M-25.0%
$4.47M-0.3%$4.48M-1.8%$4.57M-0.1%$4.57M+1.3%$4.51M+0.6%
$1.28M+180%$458K+22.8%$373K-94.4%$6.66M-39.0%$10.92M-24.5%
$1.91M-2.8%$1.97M-13.2%$2.27M-19.9%$2.84M+8.4%$2.62M-5.2%
-$6.44M+8.9%-$7.07M+87.0%-$54.59M-572%-$8.13M+60.7%-$20.68M+12.6%
$50.89M-16.5%$60.96M
$625K-3.8%$650K-16.7%$780K-51.9%$1.62M-36.1%$2.54M-18.6%
$23.87M+10.8%$21.54M+22.5%$17.59M+19.7%$14.7M+25,682%$57K
$2.29M-7.8%$2.48M+31.4%$1.89M-57.3%$4.43M
-$1.14M-5.8%-$1.08M+22.3%-$1.38M-22.0%-$1.13M-73.9%-$652K+15.0%
$4.75M+3.6%$4.58M-12.6%$5.24M+1.9%$5.14M-12.4%$5.87M-7.8%
$476K-35.3%$736K-13.5%$851K-2.4%$872K+4.2%$837K+24.7%
$18.76M-4.0%$19.55M-1.4%$19.82M+0.4%$19.74M+6.8%$18.48M+12.9%
$4.47M-0.3%$4.48M-1.8%$4.57M-0.1%$4.57M+1.3%$4.51M+0.6%
$2.51M+33.3%$1.88M+50.0%$1.25M+100%$627.25K
$120K-25.0%
$1.28M+180%$458K+22.8%$373K-94.4%$6.66M-39.0%$10.92M-24.5%
$4.54M-8.2%$4.94M+0.9%$4.9M-1.5%$4.97M+10.2%$4.51M+27.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Guardian Pharmacy Services generate?
Guardian Pharmacy Services (GRDN) generated $88.8M in operating cash flow over the trailing twelve months.
Where does Guardian Pharmacy Services's cash flow data come from?
Every line is extracted from Guardian Pharmacy Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.